Complement protein levels in plasma astrocyte‐derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia
Abstract Introduction Levels of complement proteins (CPs) in plasma astrocyte‐derived exosomes (ADEs) that are abnormal in Alzheimer's disease (AD) have not been assessed in mild cognitive impairment (MCI). Methods Participants (n = 20 per group) had either MCI converting to dementia within 3 y...
Main Authors: | Charisse N. Winston, Edward J. Goetzl, Janice B. Schwartz, Fanny M. Elahi, Robert A. Rissman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2018.11.002 |
Similar Items
-
Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity
by: Carlos J. Nogueras-Ortiz, et al.
Published: (2020-07-01) -
VERSATILITY OF THE COMPLEMENT SYSTEM IN NEUROINFLAMMATION, NEURODEGENERATION AND BRAIN HOMEOSTASIS
by: Franca eOrsini, et al.
Published: (2014-11-01) -
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
by: Luca eSteardo, et al.
Published: (2015-07-01) -
The Impact of Complement Genes on the Risk of Late-Onset Alzheimer’s Disease
by: Sarah M. Carpanini, et al.
Published: (2021-03-01) -
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
by: Ewa Kozela, et al.
Published: (2017-07-01)